Search research articles
Contact Us
Filters
Showing results (41-50 of 75) with videos related to
Page
of 8
Sort By:
Journal of Clinical Microbiology
|
January 27, 2012
φ(2)GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples
Paras Jain, Travis E Hartman, Nell Eisenberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 14, 2020
Electronic Dose Monitoring Identifies a High-Risk Subpopulation in the Treatment of Drug-resistant Tuberculosis and Human Immunodeficiency Virus
Jennifer R Zelnick, Amrita Daftary, Christina Hwang, et al.
Annals of Internal Medicine
|
October 20, 2010
High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers
Max R O'Donnell, Julie Jarand, Marian Loveday, et al.
Plos One
|
March 19, 2025
Three hospitalized non-critical COVID-19 subphenotypes and change in intubation or death over time: A latent class analysis with external and longitudinal validation
William S Stringer, Amy S Labar, Joshua D Geleris, et al.
Annals of Epidemiology
|
April 1, 2026
Early adherence predicts treatment outcomes and mortality in people living with HIV and multidrug-resistant tuberculosis
Kevin J Guzman, Rubeshan Perumal, Allison Wolf, et al.
Trials
|
December 1, 2023
Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trial
Jesse Ross, Rubeshan Perumal, Allison Wolf, et al.
Research Square
|
June 19, 2023
Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): Study protocol for an adaptive randomized controlled trial
Jesse E Ross, Rubeshan Perumal, Allison Wolf, et al.
Critical Care (London, England)
|
February 8, 2022
Multidimensional analysis of the host response reveals prognostic and pathogen-driven immune subtypes among adults with sepsis in Uganda
Matthew J Cummings, Barnabas Bakamutumaho, Adam Price, et al.
Lancet (London, England)
|
May 23, 2020
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
Matthew J Cummings, Matthew R Baldwin, Darryl Abrams, et al.
Thorax
|
December 25, 2024
Molecular phenotypes of critical illness confer prognostic and biological enrichment in sub-Saharan Africa: a prospective cohort study from Uganda
Matthew J Cummings, Julius J Lutwama, Alin S Tomoiaga, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 75) with videos related to
Sort By:
Page
of 8
Journal of Clinical Microbiology
|
January 27, 2012
φ(2)GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples
Paras Jain, Travis E Hartman, Nell Eisenberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 14, 2020
Electronic Dose Monitoring Identifies a High-Risk Subpopulation in the Treatment of Drug-resistant Tuberculosis and Human Immunodeficiency Virus
Jennifer R Zelnick, Amrita Daftary, Christina Hwang, et al.
Annals of Internal Medicine
|
October 20, 2010
High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers
Max R O'Donnell, Julie Jarand, Marian Loveday, et al.
Plos One
|
March 19, 2025
Three hospitalized non-critical COVID-19 subphenotypes and change in intubation or death over time: A latent class analysis with external and longitudinal validation
William S Stringer, Amy S Labar, Joshua D Geleris, et al.
Annals of Epidemiology
|
April 1, 2026
Early adherence predicts treatment outcomes and mortality in people living with HIV and multidrug-resistant tuberculosis
Kevin J Guzman, Rubeshan Perumal, Allison Wolf, et al.
Trials
|
December 1, 2023
Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): study protocol for an adaptive randomized controlled trial
Jesse Ross, Rubeshan Perumal, Allison Wolf, et al.
Research Square
|
June 19, 2023
Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa (ADAP-TIV): Study protocol for an adaptive randomized controlled trial
Jesse E Ross, Rubeshan Perumal, Allison Wolf, et al.
Critical Care (London, England)
|
February 8, 2022
Multidimensional analysis of the host response reveals prognostic and pathogen-driven immune subtypes among adults with sepsis in Uganda
Matthew J Cummings, Barnabas Bakamutumaho, Adam Price, et al.
Lancet (London, England)
|
May 23, 2020
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
Matthew J Cummings, Matthew R Baldwin, Darryl Abrams, et al.
Thorax
|
December 25, 2024
Molecular phenotypes of critical illness confer prognostic and biological enrichment in sub-Saharan Africa: a prospective cohort study from Uganda
Matthew J Cummings, Julius J Lutwama, Alin S Tomoiaga, et al.
Page
of 8